| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |